- CA$43.30m
- CA$35.94m
- 36
- 26
- 43
- 27
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.092 | 0.029 | 2.63 | 7.29 | 18.1 |
Operating Profit | -0.092 | -0.029 | -2.63 | -7.29 | -18.1 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.092 | -0.029 | -2.59 | -6.99 | -18.1 |
Net Income After Taxes | -0.092 | -0.029 | -2.59 | -6.99 | -18.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.092 | -0.029 | -2.59 | -6.99 | -18.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.092 | -0.029 | -2.59 | -6.99 | -18.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.054 | -0.012 | -0.125 | -0.119 | -0.211 |
Dividends per Share |